D.A. Davidson & CO. Increases Stock Position in iShares Biotechnology ETF $IBB

D.A. Davidson & CO. increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 181.0% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,701 shares of the financial services provider’s stock after purchasing an additional 8,825 shares during the period. D.A. Davidson & CO.’s holdings in iShares Biotechnology ETF were worth $1,978,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF in the 2nd quarter worth approximately $25,000. Berkshire Money Management Inc. bought a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $28,000. Financial Gravity Companies Inc. purchased a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth $29,000. Harbor Asset Planning Inc. bought a new stake in shares of iShares Biotechnology ETF in the second quarter worth $31,000. Finally, Trust Co. of Toledo NA OH purchased a new stake in iShares Biotechnology ETF during the second quarter valued at $32,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $172.39 on Friday. The business’s 50-day moving average is $168.14 and its two-hundred day moving average is $149.84. iShares Biotechnology ETF has a fifty-two week low of $107.43 and a fifty-two week high of $179.64.

iShares Biotechnology ETF Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 19th. Stockholders of record on Tuesday, December 16th were paid a $0.1831 dividend. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. The ex-dividend date was Tuesday, December 16th. This represents a $0.73 annualized dividend and a dividend yield of 0.4%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.